Alveolar Rhabdomyosarcoma Apr 2026

Alveolar rhabdomyosarcoma (ARMS) is a highly aggressive and rare malignant tumor that primarily affects children and teenagers, accounting for approximately 15–20% of all rhabdomyosarcoma cases. It is characterized by its rapid growth and a high tendency for early metastasis to the lymph nodes, lungs, and bone marrow. Key Educational & Clinical Articles

For a deep dive into the diagnosis, molecular biology, and treatment of ARMS, the following resources are highly valuable: alveolar rhabdomyosarcoma

: A recent 2026 study found on ResearchGate analyzes survival predictors in a contemporary cohort of nearly 600 patients. Core Characteristics of ARMS Rhabdomyosarcoma - StatPearls - NCBI Bookshelf - NIH Alveolar rhabdomyosarcoma (ARMS) is a highly aggressive and

: This guide from MyPathologyReport.ca explains complex medical terms and the significance of various findings for patients and caregivers. Core Characteristics of ARMS Rhabdomyosarcoma - StatPearls -

: For a technical look at the genetic drivers, the NIH PMC review on Molecular Targets explores the PAX3/7-FOXO1 fusion proteins that define this cancer.

: The StatPearls article on Rhabdomyosarcoma provides a comprehensive continuing education activity covering etiology, staging, and multimodal therapy (surgery, radiation, and chemotherapy).